Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial

By Proactive Investors / December 06, 2023 / www.youtube.com / Article Link

Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia ...

Recent News

Gold stocks gain on move back into metal

October 12, 2026 / www.canadianminingreport.com

Silver stocks gain over past year even as metal price weak

October 12, 2026 / www.canadianminingreport.com

Copper price estimates boosted by AOCE

October 05, 2026 / www.canadianminingreport.com

AOCE makes significant changes to metal estimates

October 05, 2026 / www.canadianminingreport.com

Big Gold still struggling overall in 2026

September 28, 2026 / www.canadianminingreport.com

See all >